Rastreio DST em mulheres >35 anos.

Screening for Chlamydial Infection - The USPSTF recommends against routinely providing screening for chlamydial infection in women ages 25 and older, whether or not they are pregnant, if they are not at increased risk.

Screening for Gonorrhea - The USPSTF recommends that clinicians screen all sexually active women, including those who are pregnant, for gonorrhea infection if they are at increased risk for infection (that is, if they are young or have other individual or population risk factors).
The USPSTF recommends against routine screening for gonorrhea infection in men and women who are at low risk for infection.

Screening for Syphilis Infection - The U.S. Preventive Services Task Force (USPSTF) strongly recommends that clinicians screen persons at increased risk for syphilis infection.
The USPSTF recommends against routine screening of asymptomatic persons who are not at increased risk for syphilis infection.

Screening for Hepatitis B Virus Infection in Nonpregnant Adolescents and Adults - The USPSTF recommends against routinely screening the general asymptomatic population for chronic hepatitis B virus infection.

Screening for HIV- The USPSTF strongly recommends that clinicians screen for human immunodeficiency virus (HIV) in all adolescents and adults at increased risk for HIV infection.
The USPSTF makes no recommendation for or against routinely screening for HIV in adolescents and adults who are not at increased risk for HIV infection

Screening for Hepatitis C in Adults - The USPSTF recommends against routine screening for hepatitis C virus (HCV) infection in asymptomatic adults who are not at increased risk.

Referncia- U.S. Preventive Services Task Force

SCREENING SEXUALLY ACTIVE PATIENTS — As noted above, all sexually active men and women should be offered routine testing for HIV infection. Also serologic screening for hepatitis B should be performed; if the patient has no evidence of prior exposure or vaccination, then immunization against hepatitis B should be offered.

Women with a history of unprotected sex or multiple sex partners should be screened annually for gonorrhea and chlamydia. Annual cervical screening should also be included.

Because of high rates of reinfection, patients diagnosed with gonorrhea should be advised to retest in three months; for patients who fail to be retested in that time period, clinicians should consider repeating gonorrhea testing in the 12 months following the initial diagnosis. Retesting should not be confused with a test of cure; test of cure is not recommended

REF: Screening for sexually transmitted infections